Greenland

Greenland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.38 (1.10 - 1.67) 2019 Modelled IHME
1.39 (1.12 - 1.67) 2018 Modelled IHME
1.39 (1.11 - 1.68) 2017 Modelled IHME
1.39 (1.13 - 1.66) 2016 Modelled IHME
1.4 (1.13 - 1.66) 2015 Modelled IHME
1.4 (1.14 - 1.65) 2014 Modelled IHME
1.4 (1.15 - 1.67) 2013 Modelled IHME
1.41 (1.15 - 1.68) 2012 Modelled IHME
1.41 (1.15 - 1.70) 2011 Modelled IHME
1.42 (1.15 - 1.70) 2010 Modelled IHME
1.42 (1.16 - 1.70) 2009 Modelled IHME
1.42 (1.16 - 1.70) 2008 Modelled IHME
1.42 (1.16 - 1.70) 2007 Modelled IHME
1.43 (1.16 - 1.71) 2006 Modelled IHME
1.43 (1.16 - 1.70) 2005 Modelled IHME
1.43 (1.16 - 1.71) 2004 Modelled IHME
1.44 (1.16 - 1.73) 2003 Modelled IHME
1.45 (1.15 - 1.74) 2002 Modelled IHME
1.45 (1.13 - 1.76) 2001 Modelled IHME
1.45 (1.13 - 1.77) 2000 Modelled IHME
1.46 (1.14 - 1.77) 1999 Modelled IHME
1.46 (1.16 - 1.77) 1998 Modelled IHME
1.46 (1.16 - 1.77) 1997 Modelled IHME
1.46 (1.17 - 1.77) 1996 Modelled IHME
1.46 (1.17 - 1.76) 1995 Modelled IHME
1.46 (1.18 - 1.76) 1994 Modelled IHME
1.46 (1.19 - 1.77) 1993 Modelled IHME
1.46 (1.19 - 1.77) 1992 Modelled IHME
1.47 (1.19 - 1.76) 1991 Modelled IHME
1.47 (1.19 - 1.78) 1990 Modelled IHME
17.5 (16.30 - 18.70) 2015 Survey/reported Borresen et a 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.58 (0.40 - 0.81) 2019 Modelled IHME
0.59 (0.40 - 0.79) 2018 Modelled IHME
0.59 (0.40 - 0.83) 2017 Modelled IHME
0.59 (0.40 - 0.79) 2016 Modelled IHME
0.59 (0.41 - 0.81) 2015 Modelled IHME
0.59 (0.41 - 0.81) 2014 Modelled IHME
0.6 (0.41 - 0.82) 2013 Modelled IHME
0.6 (0.41 - 0.83) 2012 Modelled IHME
0.61 (0.41 - 0.84) 2011 Modelled IHME
0.61 (0.41 - 0.84) 2010 Modelled IHME
0.61 (0.41 - 0.82) 2009 Modelled IHME
0.61 (0.41 - 0.81) 2008 Modelled IHME
0.61 (0.40 - 0.81) 2007 Modelled IHME
0.6 (0.40 - 0.82) 2006 Modelled IHME
0.6 (0.40 - 0.82) 2005 Modelled IHME
0.61 (0.40 - 0.83) 2004 Modelled IHME
0.62 (0.41 - 0.83) 2003 Modelled IHME
0.63 (0.41 - 0.86) 2002 Modelled IHME
0.64 (0.42 - 0.88) 2001 Modelled IHME
0.64 (0.42 - 0.91) 2000 Modelled IHME
0.64 (0.43 - 0.90) 1999 Modelled IHME
0.64 (0.43 - 0.88) 1998 Modelled IHME
0.63 (0.43 - 0.87) 1997 Modelled IHME
0.63 (0.43 - 0.87) 1996 Modelled IHME
0.63 (0.43 - 0.86) 1995 Modelled IHME
0.63 (0.44 - 0.85) 1994 Modelled IHME
0.63 (0.44 - 0.84) 1993 Modelled IHME
0.63 (0.44 - 0.84) 1992 Modelled IHME
0.64 (0.45 - 0.84) 1991 Modelled IHME
0.64 (0.44 - 0.85) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (8 - 18) 2019 Modelled IHME
13 (8 - 18) 2018 Modelled IHME
13 (9 - 19) 2017 Modelled IHME
13 (9 - 19) 2016 Modelled IHME
13 (9 - 19) 2015 Modelled IHME
13 (9 - 19) 2014 Modelled IHME
13 (9 - 19) 2013 Modelled IHME
13 (9 - 19) 2012 Modelled IHME
13 (9 - 20) 2011 Modelled IHME
13 (9 - 20) 2010 Modelled IHME
14 (9 - 20) 2009 Modelled IHME
14 (9 - 20) 2008 Modelled IHME
14 (10 - 20) 2007 Modelled IHME
14 (10 - 20) 2006 Modelled IHME
14 (10 - 20) 2005 Modelled IHME
14 (10 - 20) 2004 Modelled IHME
14 (10 - 20) 2003 Modelled IHME
14 (10 - 20) 2002 Modelled IHME
14 (10 - 20) 2001 Modelled IHME
14 (10 - 20) 2000 Modelled IHME
14 (10 - 20) 1999 Modelled IHME
14 (10 - 20) 1998 Modelled IHME
14 (10 - 20) 1997 Modelled IHME
14 (10 - 20) 1996 Modelled IHME
15 (10 - 21) 1995 Modelled IHME
15 (10 - 21) 1994 Modelled IHME
15 (11 - 21) 1993 Modelled IHME
15 (11 - 22) 1992 Modelled IHME
15 (11 - 22) 1991 Modelled IHME
16 (11 - 22) 1990 Modelled IHME
Showing out of
Show more
Technical notes
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.01 (0.83 - 1.24) 2019 Modelled IHME
1.01 (0.83 - 1.24) 2018 Modelled IHME
1.01 (0.82 - 1.25) 2017 Modelled IHME
1 (0.82 - 1.22) 2016 Modelled IHME
0.99 (0.80 - 1.22) 2015 Modelled IHME
0.99 (0.81 - 1.21) 2014 Modelled IHME
0.99 (0.81 - 1.21) 2013 Modelled IHME
0.99 (0.81 - 1.21) 2012 Modelled IHME
0.99 (0.81 - 1.21) 2011 Modelled IHME
0.99 (0.81 - 1.21) 2010 Modelled IHME
0.98 (0.81 - 1.20) 2009 Modelled IHME
0.97 (0.80 - 1.19) 2008 Modelled IHME
0.96 (0.79 - 1.17) 2007 Modelled IHME
0.95 (0.78 - 1.16) 2006 Modelled IHME
0.94 (0.76 - 1.15) 2005 Modelled IHME
0.93 (0.76 - 1.14) 2004 Modelled IHME
0.93 (0.76 - 1.14) 2003 Modelled IHME
0.92 (0.75 - 1.13) 2002 Modelled IHME
0.92 (0.74 - 1.12) 2001 Modelled IHME
0.91 (0.74 - 1.12) 2000 Modelled IHME
0.91 (0.74 - 1.11) 1999 Modelled IHME
0.91 (0.74 - 1.11) 1998 Modelled IHME
0.9 (0.73 - 1.11) 1997 Modelled IHME
0.9 (0.73 - 1.10) 1996 Modelled IHME
0.9 (0.73 - 1.10) 1995 Modelled IHME
0.9 (0.73 - 1.09) 1994 Modelled IHME
0.89 (0.72 - 1.09) 1993 Modelled IHME
0.89 (0.72 - 1.09) 1992 Modelled IHME
0.88 (0.71 - 1.08) 1991 Modelled IHME
0.88 (0.71 - 1.08) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
27 (19 - 36) 2019 Modelled IHME
26 (18 - 36) 2018 Modelled IHME
26 (18 - 35) 2017 Modelled IHME
26 (18 - 35) 2016 Modelled IHME
26 (18 - 35) 2015 Modelled IHME
26 (18 - 35) 2014 Modelled IHME
26 (18 - 35) 2013 Modelled IHME
26 (18 - 35) 2012 Modelled IHME
26 (18 - 35) 2011 Modelled IHME
26 (18 - 35) 2010 Modelled IHME
26 (18 - 35) 2009 Modelled IHME
26 (18 - 35) 2008 Modelled IHME
26 (18 - 35) 2007 Modelled IHME
26 (18 - 35) 2006 Modelled IHME
26 (18 - 35) 2005 Modelled IHME
26 (18 - 35) 2004 Modelled IHME
27 (19 - 36) 2003 Modelled IHME
27 (19 - 36) 2002 Modelled IHME
27 (19 - 36) 2001 Modelled IHME
27 (19 - 36) 2000 Modelled IHME
27 (19 - 36) 1999 Modelled IHME
27 (19 - 36) 1998 Modelled IHME
27 (19 - 36) 1997 Modelled IHME
27 (19 - 36) 1996 Modelled IHME
27 (19 - 36) 1995 Modelled IHME
26 (18 - 35) 1994 Modelled IHME
26 (18 - 35) 1993 Modelled IHME
25 (18 - 34) 1992 Modelled IHME
25 (17 - 34) 1991 Modelled IHME
25 (17 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Overview

Prevalence (national)

Modelled

HBV (HBsAg+)
1.38 (%)
2019
(1.1 - 1.67(%))
IHME
HCV (RNA/cAg+)
1.01 (%)
2019
(0.83 - 1.24(%))
IHME

Survey/surveillance

HBV (HBsAg+)
17.5 (%)
2015
(16.3 - 18.7(%))
Borresen et a 2015
No data available

Hepatitis related deaths (national)

Modelled

HBV
1
2019
(1 - 2)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
5
2019
(3 - 6)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.58 (%)
2019, latest modelled
(0.40 - 0.81(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines